Go to the list of all blogs
Anna G's Avatar
published in Blogs
Jun 17, 2023
How to Gain Profits and Minimize Risks when Trading Stocks

How to Gain Profits and Minimize Risks when Trading Stocks

Looking to invest your money in the stock market? While leaving your money there for a few years can yield a ten percent return, real traders know that actively trading and using derivatives is the way to make a significant profit while minimizing risk.

Derivatives are contracts between two parties that are based on the price of a financial asset, such as a stock or bond. The value of the derivative is derived from the current asset value, but it is not equal to it. Essentially, derivatives allow traders to make calculated hypotheses about whether an asset's price will go up or down.

Successful traders don't gamble. By using technical analysis, we can generally predict when an asset's price will increase or decrease in value. This makes short-term day trades relatively easy. However, predicting long-term results is more difficult, which is why derivative payoffs are often higher.

If you're new to trading, you may be unfamiliar with chart patterns, which are used in technical analysis. These graph shapes can indicate buy and sell activities. Visit Trading 101 to learn more about chart patterns and how they can help you succeed in the stock market.

Understanding the Basics: Put and Call Options

If you're new to trading, it's important to understand stock options, one of the most common derivatives. Options are agreements that allow you to buy or sell a specific security at a predetermined price on or before a particular date. There are two types of options: put and call. Think of the put as an option to sell and the call as an option to buy.

The agreed-upon price at which the underlying security will be bought or sold is called the "strike price." Remember this term as we'll be referring to it again in the sections below. While this may seem elementary to some of you, don't worry as this lesson will become more complex as we progress.

If you're a beginner, take some time to study puts and calls. You can start by checking out our Trading Options section. What we've explained here are just the basics. Tickeron has a comprehensive knowledge base on trading that includes techniques for using options correctly.

Another derivative similar to options is a warrant. Warrants function similarly to options but are issued by companies rather than exchanges. They can be used to hedge against downside risks. Warrants are common in Hong Kong and certain European countries.

Strike Price and Break-Even Prices on Call Options

Looking to trade options? Here's what you need to know: buying an option costs significantly less than purchasing the underlying stock itself. In fact, options are sold in lots of one hundred, meaning that for an option worth $1, you can purchase one hundred shares for just $100. This amount is then added to the current value of those shares to determine the break-even price.

For instance, let's consider buying a call option on XYZ Company. If the stock is currently priced at $10 a share, you could purchase a call option at $1 per share, with a strike price of $11. If the stock reaches $11 before the option's expiration date, you can exercise the option. However, keep in mind that you won't make a profit - you'll only break even.

To be successful in options trading, it's crucial to focus on the break-even price rather than the strike price. When setting up your transaction on your trading platform, make sure to examine both numbers. Seek out strike prices below the asset's current value, with a reasonable options price. With these key considerations in mind, you'll be on your way to making informed decisions in the exciting world of options trading.

Hedging Your Stock Buys with Put Options  

Looking to trade options? Don't let fear of losing hold you back. With options, the potential upside is often much greater than the downside. Take the example of XYZ stock: if it goes up to $12 a share, you could make a 100% return on your investment in just a few days. And if it doesn't go your way, the most you can lose is the price you paid for the option.

But what about put options, which allow you to sell a stock at a certain price? Even if you think the stock will go up, it's always wise to have a plan in case things don't go as expected. With a put option, you can limit your potential losses while still benefiting from any gains.

For instance, let's say you buy 100 shares of XYZ at $10 each, spending $1000. Then, you buy a put option with a strike price of $10 as well, costing you $100. If the stock goes down, you can exercise the option and sell it at the strike price, limiting your losses to just $100. And if the stock goes up, you still have the potential for a capital gain on the stock, even if you lose the $100 you spent on the put.

In short, options can be a powerful tool for traders, both for potential gains and for risk management. Don't be afraid to explore your options and find the strategies that work best for you. 

The Leverage Advantages of Futures Contracts

Options provide flexibility, allowing you to either exercise them or let them expire and take the loss. Futures contracts come in two sizes: standard contracts with a 250x multiplier, and mini contracts that are traded at one-fifth of that size.

Because futures contracts involve a large obligation and allow traders to buy and sell them for significantly less than their cash value, they offer a high degree of leverage. This leverage can boost profits, but it can also lead to substantial losses.

Corporations often purchase futures contracts to lock in the price of commodities needed for production, while traders use them for speculation and to diversify their trading efforts. Betting on prices to go up is referred to as going "long," while speculating on a decline is known as taking a "short" position.

Simplifying the Math for Derivatives

If you're new to derivatives trading, it's normal to feel a bit overwhelmed by the complexity of it all. However, at its core, derivatives trading is simply a matter of weighing risk versus reward. It's like hedging your bets, ensuring that you're prepared for whatever the market may throw your way. Of course, predicting market trends is never foolproof, but traders often use technical analysis to gain insight into what might happen next.

Consider this scenario: XYZ Company's shares are currently trading at $10 each, but this is below their previous high of $12 from just a month ago. Based on past performance, there was a drop right before that spike. If the stock's previous value was $8, you could be looking at the tail end of a head and shoulders chart pattern, which is a bullish buy indicator. However, this pattern could also be upside down, indicating a bear market instead.

So, what should you do? The answer is to hedge with options. If your analysis indicates that the stock will go up, you can buy the position. At the same time, you can purchase a put option on the current value to minimize potential losses. This way, you'll either lose the price of the put or make money on the stock trade – the math is simple.

While derivatives trading can be daunting, there are ways to manage risk and improve your chances of success. By staying informed and using tools like options, you can make smarter, more informed decisions in the market.

Diversifying a Portfolio by Hedging with Derivatives

Looking to place a bet on a horse race with two favorites? The same principle applies to the current pharmaceutical race to develop a Covid-19 vaccine on Wall Street. With Moderna (MRNA) and AstraZeneca (AZN) leading the way, experts recommend betting on both to increase your chances of success.

 

Investing in the stock market can be an exciting and potentially lucrative endeavor. Moderna and AstraZeneca are two pharmaceutical companies that have been making headlines recently. Moderna's chart pattern shows several pennants and flags, which can be good indicators for active traders. Meanwhile, AstraZeneca is currently coming out of a second cup and handle formation, and on a slight downslope to enter a third.

However, it's important to keep in mind that investing always comes with a certain level of risk. While successful completion of a working vaccine could potentially launch the winning company's stock into the stratosphere, there are no guarantees. That said, for those who are willing to take the risk, one strategy could be to buy long options on both Moderna and AstraZeneca. This way, if one company's stock does take off, it could result in significant profits, while the other may result in a minimal loss. As always, it's important to do your research and consult with a financial advisor before making any investment decisions.

Hedging for Market-Moving Events

As the United States gears up for a presidential change, experts are bracing for potential market turbulence in November. While technical analysis may not definitively predict this outcome, it's a valid concern that should not be ignored. Fortunately, savvy traders can take proactive measures to safeguard their investments. One option is purchasing put options to hedge against potential losses, while another is investing in S&P Futures contracts for added security.

A similar trend can be observed when comparing Brent Oil (BNO) to electric vehicle (EV) stocks. Historically, when oil prices drop, EV stocks tend to soar. While this correlation may seem anecdotal, it's a phenomenon worth exploring for traders looking to diversify their portfolio. It's worth noting that while oil stocks are often favored by day traders, EV stocks could serve as a hedge against potential losses.

The unprecedented global pandemic of 2020 caused economic turmoil and strained healthcare systems worldwide. While this presented new challenges for hospitals and healthcare providers, it also created unique opportunities for traders who capitalized on market volatility. For example, call option holders on Amazon, Netflix, and Shopify were able to make millions during the pandemic-induced shutdown. With the market constantly in flux, it's essential for traders to remain vigilant, adaptable, and open to new possibilities.

Learn More about Derivatives at Tickeron

If we've done our job correctly, you're now ready to delve deeper into the world of derivatives. This article serves as a starting point, but it only scratches the surface of what you can accomplish by trading options, futures, and warrants.

For a more comprehensive understanding, we recommend reading our section on trading options. As a beginner, it's crucial to review and digest all the material in that section before venturing into this market. However, with proper preparation, trading options can be a lucrative endeavor. So, get started with the basics and unlock the potential for great returns.

Looking for a way to be fully prepared to conquer the market? Look no further! Our premium products are just what you need. As a new trader, you'll find our AI Pattern Search Engine and the AI Trend Prediction Engine incredibly useful. And for those who are more experienced, our Screener is the perfect tool to help you narrow down your search and keep an eye on your securities for an extended period.

We've gone above and beyond to make sure our products are top-notch. Our team has explored nearly every existing method, from price patterns to trend indicators to oscillators, using neural networks and deep historical backtests. This has allowed us to create a pool of trading algorithms that work together seamlessly to help our AI Robots effectively determine the key points of change in market trends. Don't miss out on the opportunity to take your trading to the next level with our premium products!

Related Ticker: AAPL

AAPL in upward trend: price may jump up because it broke its lower Bollinger Band on July 31, 2026

AAPL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 29 cases where AAPL's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

AAPL moved above its 50-day moving average on August 05, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AAPL crossed bullishly above the 50-day moving average on July 08, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AAPL advanced for three days, in of 354 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 294 cases where AAPL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for AAPL moved out of overbought territory on July 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 46 similar instances where the indicator moved out of overbought territory. In of the 46 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on July 31, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AAPL as a result. In of 65 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AAPL turned negative on July 31, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AAPL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AAPL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: AAPL's P/B Ratio (41.841) is very high in comparison to the industry average of (5.431). P/E Ratio (35.351) is within average values for comparable stocks, (118.666). AAPL's Projected Growth (PEG Ratio) (2.486) is slightly higher than the industry average of (1.397). Dividend Yield (0.003) settles around the average of (4.670) among similar stocks. P/S Ratio (9.756) is also within normal values, averaging (3.038).

Notable companies

The most notable companies in this group are Apple (NASDAQ:AAPL), GoPro (NASDAQ:GPRO).

Industry description

Computer peripherals connect to a computer system to add functionality or to get information from or put information into computers. Think hard disk drive, data storage systems, cloud storage devices, printer and scanner, or mouse, keyboard etc. Some of the major companies operating in the computer peripherals industry include Western Digital Corporation, Seagate Technology PLC, NetApp, Inc., Zebra Technologies Corporation, and Xerox Holdings Corp.

Market Cap

The average market capitalization across the Computer Peripherals Industry is 244.48B. The market cap for tickers in the group ranges from 1.2K to 4.5T. AAPL holds the highest valuation in this group at 4.5T. The lowest valued company is DPSM at 1.2K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Peripherals Industry was -1%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was -24%. WLDS experienced the highest price growth at 20%, while FXHO experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the Computer Peripherals Industry was -33%. For the same stocks of the Industry, the average monthly volume growth was -7% and the average quarterly volume growth was -42%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 45
P/E Growth Rating: 55
Price Growth Rating: 68
SMR Rating: 85
Profit Risk Rating: 94
Seasonality Score: 4 (-100 ... +100)
View a ticker or compare two or three
AAPL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of mobile communication, media devices, personal computers, and portable digital music players

Industry ComputerPeripherals

Profile
Details
Industry
Telecommunications Equipment
Address
One Apple Park Way
Phone
+1 408 996-1010
Employees
166000
Web
https://www.apple.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.